DSCAM and breast cancer: Indeed, DSCAM-AS1 expression was observed to be increasingly expressed from well to less differentiated BCs and, noteworthy, DSCAM-AS1 expression was positively related to disease relapse in three datasets, as previously reported in an independent BC cohort from the study of Sun and colleagues [11].